Complete Filing Data
Surrozen, Inc./DE reported Stockholders Equity of -$187.76 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Surrozen, Inc./DE did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$242.0M | -$63.6M | -$43.0M | -$36.0M | -$54.6M | -$32.7M |
| Revenue * | $3.5M | $10.7M | $0.00 | $12.5M | $0.00 | |
| Operating Income Loss | -$42.1M | -$25.5M | -$45.8M | -$44.3M | -$54.4M | -$32.8M |
| Research And Development Expense | $29.4M | $21.1M | $27.2M | $37.0M | $40.2M | $25.7M |
| Operating Expenses | $45.6M | $36.2M | $45.8M | $56.8M | $54.4M | $32.8M |
| General And Administrative Expense | $16.2M | $15.1M | $15.8M | $19.8M | $14.2M | $7.1M |
| Other Nonoperating Income Expense | -$26.3M | -$19.3M | $398.0K | $7.6M | -$329.0K | $0.00 |
| Comprehensive Income Net Of Tax | -$63.6M | -$42.8M | -$36.1M | -$54.8M | -$32.7M | |
| Other Comprehensive Income Loss Net Of Tax | $241.0K | -$122.0K | -$119.0K | |||
| Restructuring Expenses | $0.00 | $2.8M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$71.6M | $39.7M | -$27.0M | -$1.4M | -$25.3M | -$8.8M | -$10.4M | -$9.4M | -$14.3M | -$13.4M | -$13.9M | -$7.9M | -$14.0M | -$12.7M | -$13.0M | -$441.3K | -$8.6M | -$7.0M | -$6.3M |
| Revenue * | $983.0K | $983.0K | $983.0K | $10.0M | $0.00 | $0.00 | $0.00 | ||||||||||||
| Operating Income Loss | -$10.9M | -$9.0M | -$9.6M | $1.2M | -$9.0M | -$9.1M | -$11.2M | -$10.3M | -$14.6M | -$13.6M | -$14.1M | -$14.5M | -$13.7M | -$12.7M | -$13.0M | -$438.8K | -$8.6M | ||
| Research And Development Expense | $7.8M | $6.0M | $6.6M | $5.2M | $5.3M | $5.2M | $6.1M | $6.9M | $8.1M | $8.6M | $9.6M | $9.4M | $10.4M | $10.3M | $8.6M | $7.0M | |||
| Operating Expenses | $11.9M | $10.0M | $10.5M | $8.8M | $9.0M | $9.1M | $11.2M | $10.3M | $14.6M | $13.6M | $14.1M | $14.5M | $13.7M | $12.7M | $13.0M | $8.6M | |||
| General And Administrative Expense | $4.1M | $4.0M | $4.0M | $3.6M | $3.7M | $3.9M | $3.6M | $3.3M | $5.3M | $5.0M | $4.5M | $5.1M | $3.3M | $2.4M | $4.4M | $1.7M | |||
| Other Nonoperating Income Expense | -$20.9M | $16.2M | $38.0M | -$3.1M | $3.7M | -$85.0K | $83.0K | $265.0K | -$252.0K | $50.0K | $87.0K | $6.5M | -$328.0K | $0.00 | $0.00 | ||||
| Comprehensive Income Net Of Tax | -$1.4M | -$25.3M | -$8.8M | -$10.4M | -$9.3M | -$14.1M | -$13.3M | -$14.0M | -$8.3M | -$14.0M | -$12.7M | -$13.0M | -$8.6M | ||||||
| Other Comprehensive Income Loss Net Of Tax | -$4.0K | $55.0K | $191.0K | $52.0K | $47.0K | -$310.0K | -$16.0K | ||||||||||||
| Restructuring Expenses | $0.00 | $0.00 | $0.00 | $1.5M | $0.00 | $1.2M | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$187.8M | -$21.4M | $37.9M | $76.0M | $109.7M | $47.3M | $29.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $89.9M | $35.3M | $36.7M | $25.1M | $33.5M | $35.4M | $29.5M |
| Cash And Cash Equivalents At Carrying Value | $89.2M | $34.6M | $36.0M | $24.7M | $33.1M | $35.0M | |
| Unrealized Gain Loss On Investments | $0.00 | $241.0K | -$122.0K | -$119.0K | $0.00 | ||
| Warrant Liability | $112.5M | $55.9M | $115.0K | $326.0K | $8.3M | $0.00 | |
| Retained Earnings Accumulated Deficit | -$527.3M | -$285.3M | -$221.7M | -$178.7M | -$142.6M | -$88.0M | |
| Liabilities And Stockholders Equity | $98.7M | $48.5M | $46.1M | $89.4M | $137.2M | $62.1M | |
| Assets | $98.7M | $48.5M | $46.1M | $89.4M | $137.2M | $62.1M | |
| Liabilities | $286.5M | $69.8M | $8.1M | $13.4M | $27.5M | $14.8M | |
| Assets Current | $91.6M | $38.9M | $41.1M | $81.3M | $105.2M | $50.2M | |
| Liabilities Current | $9.9M | $7.3M | $7.1M | $9.7M | $13.6M | $7.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $54.7M | -$1.5M | $11.6M | -$8.4M | -$1.9M | $5.9M | |
| Accrued Liabilities Current | $7.9M | $5.2M | $4.1M | $6.8M | $8.7M | $3.4M | |
| Restricted Cash Noncurrent | $688.0K | $688.0K | $688.0K | $405.0K | $405.0K | $405.0K | |
| Restricted Cash And Cash Equivalents At Carrying Value | $89.9M | $35.3M | $36.7M | $25.1M | $33.5M | $35.4M | |
| Restricted Cash | $688.0K | $688.0K | $688.0K | $405.0K | $405.0K | $405.0K | |
| Property Plant And Equipment Net | $433.0K | $562.0K | $2.0M | $3.6M | $4.8M | $5.8M | |
| Prepaid Expense And Other Assets Current | $2.1M | $1.8M | $2.9M | $3.5M | $3.3M | $1.0M | |
| Other Assets Noncurrent | $46.0K | $331.0K | $402.0K | $827.0K | $549.0K | $39.0K | |
| Operating Lease Right Of Use Asset Amortization Expense | $1.8M | $1.5M | $1.3M | $1.3M | $1.2M | $992.0K | |
| Operating Lease Right Of Use Asset | $6.0M | $7.8M | $1.9M | $3.3M | $4.6M | $5.6M | |
| Operating Lease Liability Noncurrent | $5.3M | $6.6M | $882.0K | $3.4M | $5.6M | $7.5M | |
| Operating Lease Liability Current | $1.3M | $1.8M | $2.5M | $2.2M | $2.2M | $2.1M | |
| Common Stock Value | $1.0K | $0.00 | $0.00 | $0.00 | $4.0K | $2.0K | |
| Accounts Payable Current | $728.0K | $306.0K | $525.0K | $658.0K | $2.7M | $1.8M | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Accounts Receivable Net Current | $0.00 | $2.0M | $2.2M | $2.0M | $0.00 | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $0.00 | -$241.0K | -$119.0K | $0.00 | |||
| Marketable Securities Current | $0.00 | $51.1M | $68.8M | $14.2M | |||
| Reclassification To Liability For Early Exercised Stock Options | $0.00 | $225.0K | $150.0K | ||||
| Issuance Of Common Stock As A Commitment Fee Under Equity Purchase Agreement | $0.00 | $273.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$23.5M | $47.1M | $5.7M | $5.7M | $6.1M | $30.1M | $45.5M | $55.1M | $63.0M | $77.5M | $89.7M | $102.7M | $123.7M | $22.8M | $34.9M | $57.9M | $66.4M | $23.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $82.0M | $91.1M | $102.3M | $31.7M | $38.5M | $28.0M | $34.4M | $36.9M | $28.2M | $25.9M | $17.3M | $14.7M | $61.5M | $19.3M | $23.8M | $59.3M | |||
| Cash And Cash Equivalents At Carrying Value | $81.3M | $90.4M | $101.6M | $31.0M | $37.8M | $27.3M | $34.0M | $36.5M | $27.8M | $25.5M | $16.9M | $14.3M | $61.1M | $18.9M | $23.4M | $58.9M | |||
| Unrealized Gain Loss On Investments | $0.00 | $0.00 | $0.00 | -$4.0K | $55.0K | $191.0K | $52.0K | -$47.0K | -$310.0K | -$16.0K | $0.00 | $0.00 | -$8.4K | $0.00 | |||||
| Warrant Liability | $53.5M | $32.6M | $49.4M | $36.2M | $33.0M | $178.0K | $243.0K | $326.0K | $591.0K | $1.3M | $1.4M | $1.8M | $8.3M | $5.1M | $2.6M | ||||
| Retained Earnings Accumulated Deficit | -$344.1M | -$272.5M | -$312.2M | -$257.2M | -$255.8M | -$230.5M | -$212.8M | -$202.3M | -$193.0M | -$177.9M | -$164.5M | -$150.6M | -$127.7M | -$5.9M | -$2.4M | ||||
| Liabilities And Stockholders Equity | $94.0M | $102.7M | $114.8M | $48.0M | $45.1M | $36.7M | $54.0M | $64.0M | $74.2M | $91.4M | $104.1M | $117.7M | $150.6M | $92.9M | $93.4M | ||||
| Assets | $94.0M | $102.7M | $114.8M | $48.0M | $45.1M | $36.7M | $54.0M | $64.0M | $74.2M | $91.4M | $104.1M | $117.7M | $150.6M | $92.9M | $93.4M | ||||
| Liabilities | $117.6M | $55.6M | $109.2M | $42.3M | $39.0M | $6.6M | $8.4M | $8.9M | $11.2M | $13.9M | $14.4M | $15.0M | $26.9M | $9.9M | $6.8M | ||||
| Assets Current | $85.9M | $94.2M | $106.0M | $45.3M | $41.6M | $32.0M | $48.4M | $57.6M | $67.0M | $82.7M | $94.8M | $95.7M | $114.0M | $917.5K | $1.4M | ||||
| Liabilities Current | $6.5M | $5.7M | $10.6M | $6.1M | $6.0M | $6.2M | $6.7M | $6.5M | $7.8M | $8.7M | $8.5M | $8.1M | $12.5M | $1.5M | $986.6K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $67.1M | -$8.8M | $3.1M | -$18.8M | -$11.6M | $987.2K | |||||||||||||
| Accrued Liabilities Current | $4.7M | $4.2M | $9.1M | $4.3M | $3.6M | $3.5M | $4.0M | $3.9M | $5.3M | $6.1M | $6.0M | $4.9M | $8.5M | $1.5M | $986.6K | ||||
| Restricted Cash Noncurrent | $688.0K | $688.0K | $688.0K | $688.0K | $688.0K | $688.0K | $426.0K | $405.0K | $405.0K | $405.0K | $405.0K | $405.0K | $405.0K | ||||||
| Restricted Cash And Cash Equivalents At Carrying Value | $82.0M | $91.1M | $102.3M | $31.7M | $38.5M | $28.0M | $34.4M | $36.9M | $28.2M | $25.9M | $17.3M | $14.7M | $61.5M | $19.3M | $23.8M | $59.3M | |||
| Restricted Cash | $688.0K | $688.0K | $688.0K | $688.0K | $688.0K | $688.0K | $426.0K | $405.0K | $405.0K | $405.0K | $405.0K | $405.0K | $405.0K | $405.0K | $405.0K | $405.0K | |||
| Property Plant And Equipment Net | $139.0K | $176.0K | $295.0K | $856.0K | $1.2M | $1.6M | $2.5M | $3.0M | $3.4M | $3.9M | $4.2M | $4.7M | $5.2M | ||||||
| Prepaid Expense And Other Assets Current | $2.0M | $1.3M | $1.7M | $2.1M | $1.8M | $2.6M | $2.9M | $2.2M | $3.3M | $4.3M | $2.1M | $3.2M | $3.8M | ||||||
| Other Assets Noncurrent | $64.0K | $82.0K | $101.0K | $351.0K | $373.0K | $897.0K | $376.0K | $394.0K | $416.0K | $846.0K | $866.0K | $904.0K | $925.0K | ||||||
| Operating Lease Right Of Use Asset Amortization Expense | $451.0K | $357.0K | $301.0K | $367.0K | $309.0K | ||||||||||||||
| Operating Lease Right Of Use Asset | $6.5M | $6.9M | $7.4M | $817.0K | $1.2M | $1.5M | $2.3M | $2.7M | $3.0M | $3.6M | $3.8M | $4.2M | $4.9M | ||||||
| Operating Lease Liability Noncurrent | $5.8M | $6.3M | $6.8M | $0.00 | $0.00 | $223.0K | $1.5M | $2.2M | $2.8M | $4.0M | $4.5M | $5.1M | $6.1M | ||||||
| Operating Lease Liability Current | $1.2M | $1.2M | $1.2M | $1.5M | $2.2M | $2.6M | $2.4M | $2.4M | $2.3M | $2.2M | $2.1M | $2.1M | $2.2M | ||||||
| Common Stock Value | $1.0K | $1.0K | $1.0K | $0.00 | $0.00 | $0.00 | $3.0K | $3.0K | $3.0K | $4.0K | $4.0K | $4.0K | $4.0K | ||||||
| Accounts Payable Current | $538.0K | $354.0K | $302.0K | $276.0K | $173.0K | $131.0K | $287.0K | $186.0K | $171.0K | $362.0K | $418.0K | $1.0M | $1.8M | ||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Accounts Receivable Net Current | $2.3M | $2.3M | $2.1M | $12.2M | $2.1M | $2.1M | $2.0M | $2.0M | $2.0M | ||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.0K | $5.0K | -$50.0K | -$424.0K | -$476.0K | -$429.0K | -$16.0K | ||||||||||||
| Marketable Securities Current | $9.5M | $16.9M | $33.9M | $52.9M | $75.8M | $78.2M | |||||||||||||
| Reclassification To Liability For Early Exercised Stock Options | $0.00 | $120.0K | |||||||||||||||||
| Issuance Of Common Stock As A Commitment Fee Under Equity Purchase Agreement | $273.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $3.8M | $4.1M | $4.4M | $4.5M | $2.3M | $635.0K |
| Net Cash Provided By Used In Operating Activities | -$30.2M | -$17.6M | -$40.4M | -$44.1M | -$48.8M | -$29.1M |
| Increase Decrease In Accrued Liabilities | $2.5M | $1.1M | -$2.6M | -$1.8M | $3.8M | $1.9M |
| Net Cash Provided By Used In Investing Activities | -$128.0K | -$26.0K | $51.7M | $38.3M | -$77.7M | -$15.1M |
| Net Cash Provided By Used In Financing Activities | $85.1M | $16.2M | $276.0K | -$2.6M | $124.6M | $50.1M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $67.0K | -$1.1M | -$915.0K | $50.0K | $2.3M | $732.0K |
| Share Based Compensation | $3.8M | $4.1M | $4.4M | $4.5M | $2.3M | $635.0K |
| Payments To Acquire Property Plant And Equipment | $128.0K | $26.0K | $398.0K | $728.0K | $1.3M | $874.0K |
| Increase Decrease In Other Operating Capital Net | -$72.0K | -$71.0K | -$62.0K | $379.0K | $510.0K | -$10.0K |
| Increase Decrease In Operating Lease Liability | -$1.8M | -$2.3M | -$2.2M | -$2.2M | -$2.1M | -$1.7M |
| Increase Decrease In Accounts Payable | $142.0K | -$228.0K | -$133.0K | -$2.0M | $857.0K | $537.0K |
| Payments To Acquire Marketable Securities | $0.00 | $28.0M | $29.6M | $91.7M | $14.2M | |
| Proceeds From Sale And Maturity Of Marketable Securities | $0.00 | $80.2M | $68.6M | $14.2M | $0.00 | |
| Proceeds From Issuance Of Common Stock | $74.7M | $16.0M | $0.00 | $0.00 | $124.2M | $0.00 |
| Proceeds From Stock Options Exercised | $87.0K | $39.0K | $3.0K | $0.00 | $411.0K | $167.0K |
| Payments To Acquire Productive Assets | $280.0K | $9.0K | $0.00 | $85.0K | $22.0K | $267.0K |
| Proceeds From Issuance Of Common Stock Upon Employee Stock Plan Purchases | $198.0K | $94.0K | $332.0K | $143.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $1.0M | $994.0K | $834.0K | $1.0M | $1.1M | $1.0M | $913.0K | $1.2M | $1.1M | $1.1M | $979.0K | $916.0K | $616.0K | $532.0K | $475.0K | $140.0K | $128.0K | $180.0K | |
| Net Cash Provided By Used In Operating Activities | -$9.3M | -$8.7M | -$14.2M | -$18.4M | -$10.3M | -$934.0K | |||||||||||||
| Increase Decrease In Accrued Liabilities | -$1.2M | -$1.1M | -$1.4M | -$3.8M | $1.8M | $290.1K | |||||||||||||
| Net Cash Provided By Used In Investing Activities | -$27.0K | -$7.0K | $17.3M | -$412.0K | -$1.4M | -$92.0M | |||||||||||||
| Net Cash Provided By Used In Financing Activities | $76.4M | $0.00 | -$39.0K | $0.00 | $196.0K | $93.9M | |||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$305.0K | -$340.0K | -$592.0K | -$274.0K | $328.0K | ||||||||||||||
| Share Based Compensation | $834.0K | $1.0M | $1.1M | $916.0K | $475.0K | ||||||||||||||
| Payments To Acquire Property Plant And Equipment | $27.0K | $7.0K | $315.0K | $412.0K | $343.0K | ||||||||||||||
| Increase Decrease In Other Operating Capital Net | -$17.0K | -$5.0K | $2.0K | $24.0K | $1.0K | ||||||||||||||
| Increase Decrease In Operating Lease Liability | -$501.0K | -$593.0K | -$525.0K | -$576.0K | -$507.0K | ||||||||||||||
| Increase Decrease In Accounts Payable | -$4.0K | -$394.0K | -$487.0K | -$1.8M | $431.0K | ||||||||||||||
| Payments To Acquire Marketable Securities | $0.00 | $7.9M | $0.00 | $1.1M | |||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $0.00 | $25.5M | $0.00 | ||||||||||||||||
| Proceeds From Issuance Of Common Stock | $76.4M | $0.00 | |||||||||||||||||
| Proceeds From Stock Options Exercised | $0.00 | $196.0K | |||||||||||||||||
| Payments To Acquire Productive Assets | $0.00 | $85.0K | $0.00 | $37.0K | |||||||||||||||
| Proceeds From Issuance Of Common Stock Upon Employee Stock Plan Purchases |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$32.37 | -$21.67 | -$21.33 | -$15.56 | -$2.21 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 7.5K | 2.9K | 2.0K | 2.3K | 24.7K | |
| Weighted Average Number Of Diluted Shares Outstanding | 7.5K | 2.9K | 2.0K | 2.3K | 24.7K | |
| Earnings Per Share Basic | $-32.37 | $-21.67 | $-21.33 | $-15.56 | $-2.21 | |
| Common Stock Shares Outstanding | 9.8M | 3.3M | 2.1M | 2.0M | 35.0M | 18.3M |
| Common Stock Shares Issued | 9.8M | 3.3M | 2.1M | 2.0M | 35.0M | 18.3M |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$8.36 | $2.55 | -$7.43 | -$0.44 | -$7.99 | -$4.24 | -$5.14 | -$4.68 | -$7.16 | -$0.38 | -$0.40 | -$0.23 | -$0.51 | -$0.69 | -$0.72 | -$0.47 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0K | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 1.0M | 1.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 8.6K | 8.5K | 3.6K | 3.2K | 3.2K | 2.1K | 2.0M | 2.0M | 2.0K | 35.0M | 34.9M | 34.9M | 27.4M | 18.2M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 8.6K | 8.5K | 3.6K | 3.2K | 3.2K | 2.1K | 2.0M | 2.0M | 2.0K | 35.0M | 34.9M | 34.9M | 27.4M | 18.2M | ||
| Earnings Per Share Basic | $-8.36 | $2.55 | $-7.43 | $-0.44 | $-7.99 | $-4.24 | $-5.14 | $-4.68 | $-7.16 | $-0.38 | $-0.40 | $-0.23 | $-0.51 | $-0.69 | ||
| Common Stock Shares Outstanding | 8.6M | 8.6M | 8.5M | 3.3M | 3.2M | 2.1M | 30.6M | 30.6M | 30.1M | 35.1M | 35.1M | 35.1M | 35.0M | |||
| Common Stock Shares Issued | 8.6M | 8.6M | 8.5M | 3.3M | 3.2M | 2.1M | 30.6M | 30.6M | 30.1M | 35.1M | 35.1M | 35.1M | 35.0M | |||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Investment Income Interest | $3.0M | $1.7M | $2.3M | $781.0K | $72.0K | $91.0K |
| Additional Paid In Capital | $339.5M | $263.9M | $259.6M | $254.9M | $252.5M | $135.3M |
| Fair Value Adjustment Of Warrants | $22.8M | $17.8M | -$211.0K | -$7.9M | -$71.0K | $0.00 |
| Vesting Of Early Exercises Of Stock Options | $0.00 | $2.0K | $32.0K | $101.0K | $207.0K | $85.0K |
| Depreciation And Amortization | $537.0K | $1.4M | $1.9M | $2.0M | $2.1M | $1.9M |
| Adjustment To Additional Paid In Capital Reclassification Of Early Exercised Stock Options | $2.0K | $32.0K | $101.0K | -$225.0K | -$150.0K | |
| Adjustment To Additional Paid In Capital Early Exercise Of Stock Options Value | $207.0K | $85.0K | ||||
| Repurchase Of Early Excercised Stock Options | $0.00 | $55.0K | $16.0K | $1.0K | $1.0K | |
| Stock Issued During Period Value Stock Options Exercised | $87.0K | $39.0K | $3.0K | $411.0K | $167.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $911.0K | $1.0M | $296.0K | $431.0K | $490.0K | $385.0K | $661.0K | $623.0K | $547.0K | $198.0K | $60.0K | $49.0K | $14.0K | $7.0K | $9.0K | $5.9K | |||
| Additional Paid In Capital | $320.6M | $319.6M | $317.9M | $262.9M | $261.8M | $260.7M | $258.3M | $257.4M | $256.0M | $255.8M | $254.7M | $253.7M | $251.4M | $10.9M | $7.4M | ||||
| Fair Value Adjustment Of Warrants | -$40.6M | $63.0K | $265.0K | -$6.5M | $2.5M | $0.00 | |||||||||||||
| Vesting Of Early Exercises Of Stock Options | $0.00 | $1.0K | $13.0K | $30.0K | $30.0K | ||||||||||||||
| Depreciation And Amortization | $294.0K | $392.0K | $482.0K | $534.0K | $511.0K | ||||||||||||||
| Adjustment To Additional Paid In Capital Reclassification Of Early Exercised Stock Options | $1.0K | $6.0K | $8.0K | $13.0K | -$40.0K | -$65.0K | -$120.0K | $11.0K | $3.0K | $75.0K | |||||||||
| Adjustment To Additional Paid In Capital Early Exercise Of Stock Options Value | $6.0K | $8.0K | $13.0K | $23.0K | $27.0K | $30.0K | $48.0K | $47.0K | $30.0K | $18.0K | $20.0K | $22.0K | |||||||
| Repurchase Of Early Excercised Stock Options | $0.00 | $39.0K | $0.00 | ||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $9.0K | $3.0K | $72.0K | $109.0K | $196.0K | $14.0K | $8.0K | $84.0K |
Most recent annual filing with the SEC: March 23, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.